Skip to main content
Top
Published in: Critical Care 6/2010

Open Access 01-12-2010 | Research

Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study

Authors: Cees van Nieuwkoop, Tobias N Bonten, Jan W van't Wout, Ed J Kuijper, Geert H Groeneveld, Martin J Becker, Ted Koster, G Hanke Wattel-Louis, Nathalie M Delfos, Hans C Ablij, Eliane MS Leyten, Jaap T van Dissel

Published in: Critical Care | Issue 6/2010

Login to get access

Abstract

Introduction

Guidelines recommend that two blood cultures be performed in patients with febrile urinary tract infection (UTI), to detect bacteremia and help diagnose urosepsis. The usefulness and cost-effectiveness of this practice have been criticized. This study aimed to evaluate clinical characteristics and the biomarker procalcitonin (PCT) as an aid in predicting bacteremia.

Methods

A prospective observational multicenter cohort study included consecutive adults with febrile UTI in 35 primary care units and 8 emergency departments of 7 regional hospitals. Clinical and microbiological data were collected and PCT and time to positivity (TTP) of blood culture were measured.

Results

Of 581 evaluable patients, 136 (23%) had bacteremia. The median age was 66 years (interquartile range 46 to 78 years) and 219 (38%) were male. We evaluated three different models: a clinical model including seven bed-side characteristics, the clinical model plus PCT, and a PCT only model. The diagnostic abilities of these models as reflected by area under the curve of the receiver operating characteristic were 0.71 (95% confidence interval (CI): 0.66 to 0.76), 0.79 (95% CI: 0.75 to 0.83) and 0.73 (95% CI: 0.68 to 0.77) respectively. Calculating corresponding sensitivity and specificity for the presence of bacteremia after each step of adding a significant predictor in the model yielded that the PCT > 0.25 μg/l only model had the best diagnostic performance (sensitivity 0.95; 95% CI: 0.89 to 0.98, specificity 0.50; 95% CI: 0.46 to 0.55). Using PCT as a single decision tool, this would result in 40% fewer blood cultures being taken, while still identifying 94 to 99% of patients with bacteremia.
The TTP of E. coli positive blood cultures was linearly correlated with the PCT log value; the higher the PCT the shorter the TTP (R2 = 0.278, P = 0.007).

Conclusions

PCT accurately predicts the presence of bacteremia and bacterial load in patients with febrile UTI. This may be a helpful biomarker to limit use of blood culture resources.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB: Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med 1997, 15: 148-151. 10.1016/S0735-6757(97)90087-5CrossRefPubMed Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB: Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med 1997, 15: 148-151. 10.1016/S0735-6757(97)90087-5CrossRefPubMed
2.
go back to reference Kunin CM: Definition of acute pyelonephritis vs the urosepsis syndrome. Arch Intern Med 2003, 163: 2393-2394. 10.1001/archinte.163.19.2393-bCrossRefPubMed Kunin CM: Definition of acute pyelonephritis vs the urosepsis syndrome. Arch Intern Med 2003, 163: 2393-2394. 10.1001/archinte.163.19.2393-bCrossRefPubMed
3.
go back to reference Brown P, Ki M, Foxman B: Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics 2005, 23: 1123-1142. 10.2165/00019053-200523110-00005CrossRefPubMed Brown P, Ki M, Foxman B: Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics 2005, 23: 1123-1142. 10.2165/00019053-200523110-00005CrossRefPubMed
4.
go back to reference Foxman B, Klemstine KL, Brown PD: Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol 2003, 13: 144-150. 10.1016/S1047-2797(02)00272-7CrossRefPubMed Foxman B, Klemstine KL, Brown PD: Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol 2003, 13: 144-150. 10.1016/S1047-2797(02)00272-7CrossRefPubMed
5.
go back to reference Jerkeman M, Braconier JH: Bacteremic and non-bacteremic febrile urinary tract infection--a review of 168 hospital-treated patients. Infection 1992, 20: 143-145. 10.1007/BF01704603CrossRefPubMed Jerkeman M, Braconier JH: Bacteremic and non-bacteremic febrile urinary tract infection--a review of 168 hospital-treated patients. Infection 1992, 20: 143-145. 10.1007/BF01704603CrossRefPubMed
6.
go back to reference Leibovici L, Greenshtain S, Cohen O, Wysenbeek AJ: Toward improved empiric management of moderate to severe urinary tract infections. Arch Intern Med 1992, 152: 2481-2486. 10.1001/archinte.152.12.2481CrossRefPubMed Leibovici L, Greenshtain S, Cohen O, Wysenbeek AJ: Toward improved empiric management of moderate to severe urinary tract infections. Arch Intern Med 1992, 152: 2481-2486. 10.1001/archinte.152.12.2481CrossRefPubMed
7.
go back to reference Hsu CY, Fang HC, Chou KJ, Chen CL, Lee PT, Chung HM: The clinical impact of bacteremia in complicated acute pyelonephritis. Am J Med Sci 2006, 332: 175-180. 10.1097/00000441-200610000-00004CrossRefPubMed Hsu CY, Fang HC, Chou KJ, Chen CL, Lee PT, Chung HM: The clinical impact of bacteremia in complicated acute pyelonephritis. Am J Med Sci 2006, 332: 175-180. 10.1097/00000441-200610000-00004CrossRefPubMed
8.
go back to reference Velasco M, Martínez JA, Moreno-Martínez A, Horcajada JP, Ruiz J, Barranco M, Almela M, Vila J, Mensa J: Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary? Clin Infect Dis 2003, 37: 1127-1130. 10.1086/378291CrossRefPubMed Velasco M, Martínez JA, Moreno-Martínez A, Horcajada JP, Ruiz J, Barranco M, Almela M, Vila J, Mensa J: Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary? Clin Infect Dis 2003, 37: 1127-1130. 10.1086/378291CrossRefPubMed
9.
go back to reference Chen Y, Nitzan O, Saliba W, Chazan B, Colodner R, Raz R: Are blood cultures necessary in the management of women with complicated pyelonephritis? J Infect 2006, 53: 235-240. 10.1016/j.jinf.2005.12.005CrossRefPubMed Chen Y, Nitzan O, Saliba W, Chazan B, Colodner R, Raz R: Are blood cultures necessary in the management of women with complicated pyelonephritis? J Infect 2006, 53: 235-240. 10.1016/j.jinf.2005.12.005CrossRefPubMed
10.
go back to reference van Nieuwkoop C, van't Wout JW, Spelt IC, Becker M, Kuijper EJ, Blom JW, Assendelft WJ, van Dissel JT: Prospective cohort study of acute pyelonephritis in adults: Safety of triage towards home based oral antimicrobial treatment. J Infect 2010, 60: 114-121. 10.1016/j.jinf.2009.11.008CrossRefPubMed van Nieuwkoop C, van't Wout JW, Spelt IC, Becker M, Kuijper EJ, Blom JW, Assendelft WJ, van Dissel JT: Prospective cohort study of acute pyelonephritis in adults: Safety of triage towards home based oral antimicrobial treatment. J Infect 2010, 60: 114-121. 10.1016/j.jinf.2009.11.008CrossRefPubMed
11.
go back to reference Bahagon Y, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM: Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients. Eur J Clin Microbiol Infect Dis 2007, 26: 349-352. 10.1007/s10096-007-0287-3CrossRefPubMed Bahagon Y, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM: Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients. Eur J Clin Microbiol Infect Dis 2007, 26: 349-352. 10.1007/s10096-007-0287-3CrossRefPubMed
12.
go back to reference Jerkeman M, Braconier JH: Bacteremic and non-bacteremic febrile urinary tract infection--a review of 168 hospital-treated patients. Infection 1992, 20: 143-145. 10.1007/BF01704603CrossRefPubMed Jerkeman M, Braconier JH: Bacteremic and non-bacteremic febrile urinary tract infection--a review of 168 hospital-treated patients. Infection 1992, 20: 143-145. 10.1007/BF01704603CrossRefPubMed
13.
go back to reference Lee A, Mirrett S, Reller LB, Weinstein MP: Detection of bloodstream infections in adults: how many blood cultures are needed? J Clin Microbiol 2007, 45: 3546-3548. 10.1128/JCM.01555-07PubMedCentralCrossRefPubMed Lee A, Mirrett S, Reller LB, Weinstein MP: Detection of bloodstream infections in adults: how many blood cultures are needed? J Clin Microbiol 2007, 45: 3546-3548. 10.1128/JCM.01555-07PubMedCentralCrossRefPubMed
14.
go back to reference Gander RM, Byrd L, DeCrescenzo M, Hirany S, Bowen M, Baughman J: Impact of blood cultures drawn by phlebotomy on contamination rates and health care costs in a hospital emergency department. J Clin Microbiol 2009, 47: 1021-1024. 10.1128/JCM.02162-08PubMedCentralCrossRefPubMed Gander RM, Byrd L, DeCrescenzo M, Hirany S, Bowen M, Baughman J: Impact of blood cultures drawn by phlebotomy on contamination rates and health care costs in a hospital emergency department. J Clin Microbiol 2009, 47: 1021-1024. 10.1128/JCM.02162-08PubMedCentralCrossRefPubMed
15.
go back to reference McCaig LF, McDonald LC, Cohen AL, Kuehnert MJ: Increasing blood culture use at US hospital emergency department visits, 2001 to 2004. Ann Emerg Med 2007, 50: 42-48. 48.e1-2 10.1016/j.annemergmed.2006.12.002CrossRefPubMed McCaig LF, McDonald LC, Cohen AL, Kuehnert MJ: Increasing blood culture use at US hospital emergency department visits, 2001 to 2004. Ann Emerg Med 2007, 50: 42-48. 48.e1-2 10.1016/j.annemergmed.2006.12.002CrossRefPubMed
16.
go back to reference Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, International Surviving Sepsis Campaign Guidelines Committee, American Association of Critical-Care Nurses, American College of Chest Physicians, American College of Emergency Physicians, Canadian Critical Care Society, European Society of Clinical Microbiology and Infectious Diseases, et al.: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36: 296-327. 10.1097/01.CCM.0000298158.12101.41CrossRefPubMed Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, International Surviving Sepsis Campaign Guidelines Committee, American Association of Critical-Care Nurses, American College of Chest Physicians, American College of Emergency Physicians, Canadian Critical Care Society, European Society of Clinical Microbiology and Infectious Diseases, et al.: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36: 296-327. 10.1097/01.CCM.0000298158.12101.41CrossRefPubMed
17.
go back to reference Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA: Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007, 50: 34-41. 10.1016/j.annemergmed.2006.10.020CrossRefPubMed Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA: Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007, 50: 34-41. 10.1016/j.annemergmed.2006.10.020CrossRefPubMed
18.
go back to reference van Langevelde P, Joop K, van Loon J, Frölich M, Groeneveld PH, Westendorp RG, van Dissel JT: Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis 2000, 31: 1343-1348. 10.1086/317480CrossRefPubMed van Langevelde P, Joop K, van Loon J, Frölich M, Groeneveld PH, Westendorp RG, van Dissel JT: Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis 2000, 31: 1343-1348. 10.1086/317480CrossRefPubMed
19.
go back to reference Martínez JA, Pozo L, Almela M, Marco F, Soriano A, López F, Balasso V, Aguilar J, Mensa J: Microbial and clinical determinants of time-to-positivity in patients with bacteraemia. Clin Microbiol Infect 2007, 13: 709-716. 10.1111/j.1469-0691.2007.01736.xCrossRefPubMed Martínez JA, Pozo L, Almela M, Marco F, Soriano A, López F, Balasso V, Aguilar J, Mensa J: Microbial and clinical determinants of time-to-positivity in patients with bacteraemia. Clin Microbiol Infect 2007, 13: 709-716. 10.1111/j.1469-0691.2007.01736.xCrossRefPubMed
20.
go back to reference Wilson ML, Gaido L: Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis 2004, 38: 1150-1158. 10.1086/383029CrossRefPubMed Wilson ML, Gaido L: Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis 2004, 38: 1150-1158. 10.1086/383029CrossRefPubMed
21.
go back to reference Sun GW, Shook TL, Kay GL: Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 1996, 49: 907-916. 10.1016/0895-4356(96)00025-XCrossRefPubMed Sun GW, Shook TL, Kay GL: Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 1996, 49: 907-916. 10.1016/0895-4356(96)00025-XCrossRefPubMed
22.
go back to reference van Nieuwkoop C, Bonten TN, Wout JW, Becker MJ, Groeneveld GH, Jansen CL, van der Vorm ER, Ijzerman EP, Rothbarth PH, Termeer-Veringa EM, Kuijper EJ, van Dissel JT: Risk factors for bacteremia with uropathogen not cultured from urine in adults with febrile urinary tract infection. Clin Infect Dis 2010, 50: e69-e72. 10.1086/652657CrossRefPubMed van Nieuwkoop C, Bonten TN, Wout JW, Becker MJ, Groeneveld GH, Jansen CL, van der Vorm ER, Ijzerman EP, Rothbarth PH, Termeer-Veringa EM, Kuijper EJ, van Dissel JT: Risk factors for bacteremia with uropathogen not cultured from urine in adults with febrile urinary tract infection. Clin Infect Dis 2010, 50: e69-e72. 10.1086/652657CrossRefPubMed
23.
go back to reference Muller B, Schuetz P, Trampuz A: Circulating biomarkers as surrogates for bloodstream infections. Int J Antimicrob Agents 2007, 30: S16-23. 10.1016/j.ijantimicag.2007.06.032CrossRefPubMed Muller B, Schuetz P, Trampuz A: Circulating biomarkers as surrogates for bloodstream infections. Int J Antimicrob Agents 2007, 30: S16-23. 10.1016/j.ijantimicag.2007.06.032CrossRefPubMed
24.
go back to reference Chirouze C, Schuhmacher H, Rabaud C, Gil H, Khayat N, Estavoyer JM, May T, Hoen B: Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 2002, 35: 156-161. 10.1086/341023CrossRefPubMed Chirouze C, Schuhmacher H, Rabaud C, Gil H, Khayat N, Estavoyer JM, May T, Hoen B: Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 2002, 35: 156-161. 10.1086/341023CrossRefPubMed
25.
go back to reference Liaudat S, Dayer E, Praz G, Bille J, Troillet N: Usefulness of procalcitonin serum level for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis 2001, 20: 524-527. 10.1007/s100960100548CrossRefPubMed Liaudat S, Dayer E, Praz G, Bille J, Troillet N: Usefulness of procalcitonin serum level for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis 2001, 20: 524-527. 10.1007/s100960100548CrossRefPubMed
26.
go back to reference Müller F, Christ-Crain M, Bregenzer T, Krause M, Zimmerli W, Mueller B, Schuetz P, ProHOSP Study Group: Procalcitonin levels Predict Bacteremia in Patients with community-acquired Pneumonia: A prospective cohort trial. Chest 2010, 138: 121-129.CrossRefPubMed Müller F, Christ-Crain M, Bregenzer T, Krause M, Zimmerli W, Mueller B, Schuetz P, ProHOSP Study Group: Procalcitonin levels Predict Bacteremia in Patients with community-acquired Pneumonia: A prospective cohort trial. Chest 2010, 138: 121-129.CrossRefPubMed
27.
go back to reference Fontanarosa PB, Kaeberlein FJ, Gerson LW, Thomson RB: Difficulty in predicting bacteremia in elderly emergency patients. Ann Emerg Med 1992, 21: 842-848. 10.1016/S0196-0644(05)81032-7CrossRefPubMed Fontanarosa PB, Kaeberlein FJ, Gerson LW, Thomson RB: Difficulty in predicting bacteremia in elderly emergency patients. Ann Emerg Med 1992, 21: 842-848. 10.1016/S0196-0644(05)81032-7CrossRefPubMed
28.
go back to reference Schuetz P, Mueller B, Trampuz A: Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection 2007, 35: 352-355. 10.1007/s15010-007-7065-0CrossRefPubMed Schuetz P, Mueller B, Trampuz A: Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection 2007, 35: 352-355. 10.1007/s15010-007-7065-0CrossRefPubMed
29.
go back to reference Blot F, Schmidt E, Nitenberg G, Tancrède C, Leclercq B, Laplanche A, Andremont A: Earlier positivity of central-venous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998, 36: 105-109.PubMedCentralPubMed Blot F, Schmidt E, Nitenberg G, Tancrède C, Leclercq B, Laplanche A, Andremont A: Earlier positivity of central-venous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998, 36: 105-109.PubMedCentralPubMed
30.
go back to reference Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B, ProHOSP Study Group: Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009, 302: 1059-1066. 10.1001/jama.2009.1297CrossRefPubMed Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B, ProHOSP Study Group: Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009, 302: 1059-1066. 10.1001/jama.2009.1297CrossRefPubMed
31.
go back to reference Huang DT, Weissfeld LA, Kellum JA, Yealy DM, Kong L, Martino M, Angus DC, GenIMS Investigators: Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 2008, 52: 48-58. 10.1016/j.annemergmed.2008.01.003PubMedCentralCrossRefPubMed Huang DT, Weissfeld LA, Kellum JA, Yealy DM, Kong L, Martino M, Angus DC, GenIMS Investigators: Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 2008, 52: 48-58. 10.1016/j.annemergmed.2008.01.003PubMedCentralCrossRefPubMed
32.
go back to reference Claessens YE, Schmidt J, Batard E, Grabar S, Jegou D, Hausfater P, Kierzek G, Guérin S, Pourriat JL, Dhainaut JF, Ginsburg C, BIS Study Group: Can C-reactive protein, procalcitonin and mid-regional pro-atrial natriuretic peptide measurements guide choice of in-patient or out-patient care in acute pyelonephritis? Biomarkers In Sepsis (BIS) multicentre study. Clin Microbiol Infect 2010, 16: 753-760.CrossRefPubMed Claessens YE, Schmidt J, Batard E, Grabar S, Jegou D, Hausfater P, Kierzek G, Guérin S, Pourriat JL, Dhainaut JF, Ginsburg C, BIS Study Group: Can C-reactive protein, procalcitonin and mid-regional pro-atrial natriuretic peptide measurements guide choice of in-patient or out-patient care in acute pyelonephritis? Biomarkers In Sepsis (BIS) multicentre study. Clin Microbiol Infect 2010, 16: 753-760.CrossRefPubMed
33.
go back to reference Lemiale V, Renaud B, Moutereau S, N'Gako A, Salloum M, Calmettes MJ, Hervé J, Boraud C, Santin A, Grégo JC, Braconnier F, Roupie E: A single procalcitonin level does not predict adverse outcomes of women with pyelonephritis. Eur Urol 2007, 51: 1394-1401. 10.1016/j.eururo.2006.12.018CrossRefPubMed Lemiale V, Renaud B, Moutereau S, N'Gako A, Salloum M, Calmettes MJ, Hervé J, Boraud C, Santin A, Grégo JC, Braconnier F, Roupie E: A single procalcitonin level does not predict adverse outcomes of women with pyelonephritis. Eur Urol 2007, 51: 1394-1401. 10.1016/j.eururo.2006.12.018CrossRefPubMed
34.
go back to reference Schuetz P, Christ-Crain M, Huber AR, Muller B: Long-term stability of procalcitonin in frozen samples and comparison of Kryptor and VIDAS automated immunoassays. Clin Biochem 2010, 43: 341-344. 10.1016/j.clinbiochem.2009.08.029CrossRefPubMed Schuetz P, Christ-Crain M, Huber AR, Muller B: Long-term stability of procalcitonin in frozen samples and comparison of Kryptor and VIDAS automated immunoassays. Clin Biochem 2010, 43: 341-344. 10.1016/j.clinbiochem.2009.08.029CrossRefPubMed
Metadata
Title
Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study
Authors
Cees van Nieuwkoop
Tobias N Bonten
Jan W van't Wout
Ed J Kuijper
Geert H Groeneveld
Martin J Becker
Ted Koster
G Hanke Wattel-Louis
Nathalie M Delfos
Hans C Ablij
Eliane MS Leyten
Jaap T van Dissel
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Critical Care / Issue 6/2010
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc9328

Other articles of this Issue 6/2010

Critical Care 6/2010 Go to the issue